MedPath

CUROSURF

CUROSURF

Approved
DIN Number

02241551

Drug Class

Human

Market Date

Dec 19, 2016

Company
HC

CHIESI FARMACEUTICI S.P.A.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02241551
AIG Number0139601001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R07AA02 NATURAL PHOSPHOLIPIDS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntratracheal
AHFS Classification48:36.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PORACTANT ALFAActive
Strength: 80 MG / ML
Monograph: PORACTANT ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.